SCHEMBL3640665

SCHEMBL3640665

CCOC(=O)c1oc2cc(O)c(Cl)cc2c1C

nearest known ligand 0.53

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MAPT P10636 3/20 0.53
RAB9A P51151 2/20 0.53
NPC1 O15118 1/20 0.53
HIF1A Q16665 5/20 0.51
GPR35 Q9HC97 1/20 0.50
L3MBTL1 Q9Y468 1/20 0.50
USP2 O75604 1/20 0.48
MCL1 Q07820 1/20 0.48
BRAF P15056 1/20 0.47
EIF2AK3 Q9NZJ5 1/20 0.47
KDM4E B2RXH2 4/20 0.47
AHR P35869 1/20 0.47
TSHR P16473 2/20 0.47
PARG Q86W56 2/20 0.46
MEN1 O00255 2/20 0.46
ALDH1A1 P00352 2/20 0.46
KMT2A Q03164 2/20 0.46
HSD17B10 Q99714 2/20 0.46
SMN1; SMN2 Q16637 2/20 0.46
MAPK1 P28482 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28047026 0.94 MAPT (0.53) MAPTRAB9ANPC1HIF1AGPR35
SCHEMBL10743403 0.88 GPR35 (0.64) MAPTRAB9ANPC1HIF1AGPR35
SCHEMBL3648813 0.84 BRAF (0.44) MAPTRAB9ANPC1HIF1AL3MBTL1
SCHEMBL3646419 0.84 HIF1A (0.51) MAPTRAB9ANPC1HIF1AL3MBTL1
SCHEMBL3640653 0.81 KDM4E (0.49) MAPTRAB9ANPC1HIF1AUSP2
SCHEMBL28047029 0.81 HIF1A (0.51) MAPTRAB9ANPC1HIF1AL3MBTL1
SCHEMBL10743963 0.81 GPR35 (0.76) MAPTRAB9ANPC1GPR35MCL1
SCHEMBL11698424 0.80 KDM4E (0.47) MAPTRAB9ANPC1HIF1AL3MBTL1
SCHEMBL3647204 0.80 ALDH1A1 (0.52) MAPTRAB9ANPC1L3MBTL1USP2
SCHEMBL10737642 0.79 HIF1A (0.54) MAPTRAB9ANPC1HIF1AGPR35

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-2183237-A1 BENZOFURAN- AND BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AND USE THEREOF AS HISTAMINE 3 RECEPTOR MODULATORS F. Hoffmann-Roche AG (CH) 2010-05-12 EP disclosed
US-7534788-B2 Benzofuran and benzothiophene-2-carboxylic acid amide derivatives HOFFMANN-LA ROCHE INC. (US) 2009-05-19 US disclosed
WO-2009013195-A1 BENZOFURAN- AND BENZO[B]THIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES AND USE THEREOF AS HISTAMINE 3 RECEPTOR MODULATORS F. HOFFMANN-LA ROCHE AG (CH) 2009-01-29 WO disclosed
US-20090029976-A1 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES HOFFMANN-LA ROCHE, INC. 2009-01-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090029976-A1 BENZOFURAN AND BENZOTHIOPHENE-2-CARBOXYLIC ACID AMIDE DERIVATIVES HCAR2, HCAR1, HRH3 MAPT 1665/4885RAB9A 4200/4885NPC1 2383/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.